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Abstract. To investigate the mechanisms of ER-associ- 
ated protein degradation (ERAD), this process was re- 
constituted in vitro. Established procedures for post- 
translational translocation of radiolabeled prepro-alpha 
factor into isolated yeast microsomes were modified to 
inhibit glycosylation and to include a posttranslocation 
"chase" incubation period to monitor degradation. Gly- 
cosylation was inhibited with a glyco-acceptor peptide 
to compete for core carbohydrates, or by using a radio- 
labeled alpha factor precursor that had been genetically 
engineered to eliminate all three glycosylation  sites. In- 
hibition of glycosylation  led to the production of ungly- 
cosylated pro-alpha factor (ptxF), a processed form of 
the alpha factor precursor shown to be a substrate of 
ERAD in vivo. With this system, both glycosylated  and 
unglycosylated  forms of pro-alpha factor were stable 
throughout a 90-min chase incubation. However, the 
addition of cytosol to the chase incubation reaction in- 
duced a selective and rapid degradation of perF. These 
results directly reflect the behavior of alpha factor pre- 
cursor in vivo; i.e., paF is a substrate for ERAD, while 
glycosylated  pro-alpha factor is not. Heat inactivation 
and trypsin treatment of cytosol, as well as addition of 
ATP~/S to the chase incubations, led to a stabilization 
of po~F. ERAD was observed in sec12 microsomes, indi- 
cating that export of paF via transport vesicles was not 
required. Furthermore, paF but not glycosylated  pro- 
alpha factor was found in the supernatant of the chase 
incubation reactions, suggesting a specific transport sys- 
tem for this ERAD substrate. Finally, the degradation 
of paF was inhibited when microsomes from a yeast 
strain containing a disrupted calnexin gene were exam- 
ined. Together, these results indicate that cytosolic pro- 
tein factor(s), ATP hydrolysis, and calnexin are re- 
quired for ER-associated protein degradation in yeast, 
and suggest the cytosol as the site for degradation. 
T 
HE  presence  of aberrant  proteins  in  the  cell  has 
made necessary the evolution of efficient mecha- 
nisms for their removal. Indeed, protein degrada- 
tion is  known to  occur  in  different cell  compartments, 
most notably in the lysosome and the cytoplasm. Recently, 
the results from many studies have clearly established the 
existence  of a selective  intracellular protein degradation 
process  that removes aberrant and unassembled proteins 
from the  ER  (for review  see  Bonifacino and Klausner, 
1994).  This  ER-associated  protein  degradation process 
(ERAD) 1 operates as an essential step in the quality con- 
trol of newly synthesized proteins in the secretory pathway. 
Analyses of various protein substrates in untreated and 
permeabilized cells have indicated that proteases of the 
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mammalian lysosome  and the yeast vacuole are  not in- 
volved in ERAD, suggesting a novel proteolytic pathway 
(Chen et al., 1988; Amara et al., 1989; Finger et al., 1993; 
McCracken and Kruse, 1993; Hampton and Rine, 1994; 
and references therein). Experiments with protease inhibi- 
tors have shown that both cysteine and serine proteases 
may be involved (Wileman et al., 1991; Inoue and Simoni, 
1992; Tsao et al., 1992; Wikstrom and Lodish, 1992), but 
the identity of the responsible  protease(s) and the site of 
degradation are unknown. 
ER-associated  protein degradation is highly selective for 
specific soluble and integral membrane proteins, while the 
majority of ER resident and secreted proteins are quite 
stable  (Lippincott-Schwartz  et al.,  1988; Wileman et al., 
1990). Although the nature of this remarkable substrate 
selectivity is not yet known, it is likely that structural fea- 
tures of the protein function as degradation motifs (re- 
viewed in Bonifacino and Klausner, 1994; Schmitz et al., 
1995). 
One major success in cell biology has been the achieve- 
ment of cell-free  systems  to study protein translocation 
across  cell membranes. Such in vitro systems have been 
used to identify targeting signals and receptors, and to ex- 
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Schekman, 1994). A cell-free system for the study of ERAD 
would provide the means to dissect this pathway at the 
molecular level. Experiments with permeabilized mamma- 
lian cells have demonstrated that the selectivity and regu- 
lation of ERAD was influenced by the redox conditions of 
the ER (Young et al., 1993), and that transport out of the 
ER was not an absolute requirement for degradation (Leon- 
ard and Chen, 1987; Stafford and Bonifacino, 1991; Megis 
and Simoni, 1992; Wikstrom and Lodish, 1992). We sought 
to assemble a cell-free yeast system to study ERAD in which 
the specific contributions of both membrane and soluble 
components of the degradative process could be analyzed 
in detail. 
Established procedures for in vitro studies with ER- 
derived microsomes from yeast (Wuestehube and Schek- 
man, 1992; Brodsky and Schekman, 1993; Brodsky et al., 
1993)  were  modified to  inhibit glycosylation of translo- 
cated prepro-alpha factor, a yeast mating pheromone pre- 
cursor. In its unglycosylated form, pro-alpha factor (paF) 
is a substrate for ERAD in vivo (Caplan et al.,  1991). In 
our in vitro system, paF is selectively and rapidly degraded 
via  a  cytosol-dependent  mechanism.  Furthermore,  this 
cell-free system mimics the in vivo process of ER-associ- 
ated protein degradation, as judged by similar rates of deg- 
radation, vacuolar protease independence, and substrate 
selectivity. We used  this in vitro system to demonstrate 
that protein component(s) of the cytosol, ATP hydrolysis, 
and the  molecular chaperone calnexin, are  required  for 
ER-associated protein degradation in yeast. 
Materials and Methods 
Materials 
Strains used were RSY607 (Mata, ura3-52, 1eu2-3-112~ pep4::URA3)  pro- 
vided by R. Schekman (University of California, Berkeley); AB122 (Mata, 
prcl-407, prb l-1122, pep4-3, leu2, ura3-52) provided by A. Brake (Univer- 
sity of California, San Francisco); W303-1a (Mata, ade2-1, canl-lO0, ura3-1, 
leu2-3,112, trpl-1, h/s3-11,15) and W303-1a, CNE1  delete (Mata, ade2-1, 
canl-lO0, ura3-1,1eu2-3,112, trpl-1, his3-11,15 (cnel::LEU2)  (Parlati et al., 
1995);  W303-1B (Mats, ade2-1, canl-lO0,  ura3-1, 1eu2-3,112, trpl-1, his3- 
11,15)  and W303-1B, EUG1  delete (Match, ade2-1, canl-lO0,  ura3-1, leu2- 
3,112,  trpl-1, his3-11,15, (eugl::LEU2)  (Tachibana and  Stevens, 1992); 
pSY103  (Mats,  urn3-52,  1eu2-3,112, ade2)  and  pSY105,  SCJ1  delete 
(Mater, urn 3-52,1eu2-3,112, (scj::URA3) (Blumberg and Silver, 1991); and 
RSY263 (Mater, sec12-4, ura3-52) and RSY250 (Mater, ura3-52) provided 
by C. Barlowe (Dartmouth Medical School). The pGem2(36-3Q expres- 
sion plasmid that contains a ppaF gene with all three glycosylation sites al- 
tered to specify glutamine instead of asparagine (AGpp~F) was provided 
by D. Meyer (University of California, Los Angeles). Radiolabeled pre- 
pro-alpha factor, both wild-type (pp~F) and mutant (AGppaF), was syn- 
thesized in a yeast cell-free transcription/translation reaction essentially as 
described (Rothblatt and Meyer, 1986). Glyco-acceptor peptide, n-acetyl- 
asparaginyl-tyrosyl-threonyl-amide (NYT), was provided by W. Hansen 
(University of California, San Francisco) (Hansen and Walter, 1988). 
Preparation of Yeast Microsomes and Cytosol 
Yeast cells were grown at 20°C in YPD (1% Bacto-yeast extract, 2% Bacto- 
peptone, 2% dextrose) to a final optical density of 2  ~, at 600 nm. Yeast 
microsomes were prepared from RSY607 cells by homogenization, essen- 
tially as described (Brodsky et al., 1993), washed, and diluted with buffer- 
88  (20  mM Hepes,  pH  6.8,  150  mM KOAc, 250  mM sorbitol,  5  mM 
MgOAc) to a final concentration of ~10 mg protein/ml (OD280 = 40 in 1% 
SDS), quick-frozen in liquid nitrogen, and stored at -70°C. A yeast cyto- 
sol $100 fraction (23 mg protein/ml) was obtained from an AB122 cell ly- 
sate prepared by liquid nitrogen lysis (by centrifugation at 100,000 g) as 
previously described (Sorger and Pelham, 1987).  To produce heat inacti- 
vated cytosol, aliquots were subjected to two rounds of heating to 85°C for 
5 min, each followed by cooling on ice. To produce trypsin treated cytosol, 
420 ILl of cytosol (9.7 mg protein) was incubated with 100 ILl (2.8 units) of 
trypsin-linked agarose beads (Sigma Chemical Co., St. Louis, MO) for 30 
min at 37°C and the beads were subsequently removed by centrifugation 
according to the manufacturer's specifications. 
Translocation and In Vitro ERAD Reactions 
Reactions typically contained 60 ILl, which included an ATP regenerating 
system (1 mM ATP, 50 ILM GDP-mannose, 40 nM creatine phosphate, 0.2 
mg/ml creatine phosphokinase), 6 ILl of microsomes, and buffer 88. Mix- 
tures were prepared and held on ice unless otherwise indicated. Reactions 
were  commenced by the addition  of 200,000-300,000 cpm of wild-type 
35S-prepro-alpha  factor  or  mutant 35S-prepro-alpha  factor  lacking  the 
three consensus glycosylation acceptor sites (~4-6 p.l of radiolabeled pro- 
tein), and conducted for 50 min at 20°C.  Microsomes were pelleted from 
the translocation reaction by micro-centrifugation (12,000  rpm) at 4°C for 
4  min, gently resuspended and washed with  buffer 88  and then resus- 
pended in 60 ILl buffer-88 containing the ATP regenerating system. The 
posttranslocation incubation was at 30°C for the indicated duration, and 
was commenced by addition of cytosol (5 I~g protein per p.l of reaction), 
and/or 1.8 mM Ca  2+ and 0.5 mM DTT. After incubations were complete, 
20-iLl aliquots were  removed and placed  on ice, or mixed with trypsin 
(0.25  g/ml) or trypsin and 1% Triton X-100 and incubated at 0°C for 25 
min. Proteolysis was quenched by the addition of TCA to a final concen- 
tration of 10-20%, and the reactions were left on ice for another 15 min, 
after which they were microcentrifuged (10,000 rpm) at 4°C for 10 min. 
The pellets were washed once with 200/M of ice-cold acetone and the final 
pellet fraction was resuspended in 30 ILl of Laemmli sample buffer and 
heated to 95°C for 3 min. The samples were resolved on an 18% polyacryl- 
amide gel containing SDS and 4 M  urea. Gels were fixed in 10% acetic 
acid containirtg 25% isopropyl alcohol, dried and exposed to a Phosphor- 
imaging screen for 1-2 d. Results were visualized using a  BioRad Phos- 
phorImager and quantified by BioRad phosphor analyses software (Bio 
Rad Labs., Richmond, CA).  First order  decay curves, generated  using 
Cricket Graph software (Cricket Software, Malvern, PA) were used to de- 
termine the half-life of p~F. 
Results 
The yeast pheromone precursor, prepro-alpha factor (ppaF), 
was chosen as an ERAD reporter substrate because it is 
competent for posttranslational translocation across yeast 
microsomes in vitro (Hansen et al.,  1986; Rothblatt and 
Meyer 1986; Waters and Blobel, 1986) and in its unglyco- 
sytated form,  pro-alpha  factor  (paF)  is  a  substrate  for 
ERAD in vivo (Caplan et al., 1991). In the ER, the signal 
sequence is cleaved from ppctF, paF receives three core 
carbohydrate chains, and the glycosylated species is trans- 
ported to the Golgi complex for further processing and al- 
pha factor is ultimately secreted (reviewed in Fuller et al., 
1988). However, when glycosylation is inhibited, alpha fac- 
tor is inefficiently secreted, and pro-alpha factor accumu- 
lates in the ER and is degraded (Julius et al., 1984; Caplan 
et al., 1991). Thus, if ERAD was reconstituted in vitro, gly- 
cosylated  pro-alpha  factor  would  be  stable  while  paF 
would be degraded. 
Acceptor Peptide Inhibits Pro-Alpha 
Factor Glycosylation 
To generate a substrate for ERAD, translocation of radio- 
labeled prepro-alpha factor into isolated yeast microsomes 
was performed in the presence of a competitor for glycosy- 
lation, NYT  (see  Materials and Methods).  This peptide 
freely enters the ER where it becomes glycosylated and 
competes for available core carbohydrate chains (Hansen 
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translocated ppaF was removed by centrifugation, and the 
microsomes were incubated at 30°C to allow for degrada- 
tion  of the  translocated  protein.  The  identity of translo- 
cated  protein  was  determined  by  differential  migration 
during SDS-PAGE, based on the acquisition  of N-linked 
core carbohydrate and by the cleavage of the presequence 
(Deshaies and Schekman, 1989). Cleavage of the signal se- 
quence  resulted  in  a  species (paF)  that migrated further 
than the  untranslocated ppetF, and glycosylation resulted 
in a form (3GpetF) that migrated slower than ppetF. As ex- 
pected,  signal  sequence  cleavage  and  glycosylation  oc- 
curred in the absence of NYT peptide (Fig. 1,3GpaF) and 
glycosylation was inhibited  in the  presence of NYT pep- 
tide (Fig. 1, paF). Both forms of paF were stable and pro- 
tease protected during the 90-min chase incubation, dem- 
onstrating  the  integrity  of  the  microsomes.  However, 
based on these results we concluded that ERAD had not 
been reconstituted. 
Degradation of Unglycosylated Pro-Alpha Factor 
Requires the Addition of Cytosol 
We  reasoned  that  a  component or condition  for ERAD 
had not been met in this cell-free system. To identify the 
missing component, we first examined whether yeast cyto- 
sol would provide the absent factor(s). Translocation was 
carried out in the presence of NYT peptide, and chase in- 
cubations were supplemented with yeast cytosol. The ad- 
dition  of cytosol resulted  in  the  selective degradation  of 
Figure 1.  Glycosylation acceptor peptide inhibits glycosylation of 
paF; both glycosylated  and unglycosylated  pro-alpha factor are 
stable in  yeast microsomes.  Translocation reactions  containing 
wild-type yeast microsomes,  radiolabeled ppetF, and in the pres- 
ence or absence of 0.33 p.M NYr glycosylation acceptor peptide, 
were followed by 0-, 40-, and 90-min chase incubations  of washed 
microsomes resuspended in buffer with or without NYT glycosy- 
lation acceptor peptide. Reactions were processed as described, 
analyzed by SDS-PAGE, and visualized using a Phosphorlmager 
(see Materials and Methods).  Lane a, total TCA precipitable ma- 
terial  from  untreated  samples;  lane  b,  samples  treated  with 
trypsin to demonstrate translocated protease-protected protein; 
lane c, samples treated with trypsin and Triton X-100, showing 
depletion of translocated protein upon loss of membrane integ- 
rity. The protease protected ppetF seen in lanes b and c, is an un- 
translocated aggregated species that remains associated  with the 
microsomes and is resistant  to trypsin treatment even in the pres- 
ence of Triton-X 100 (Brodsky et al., 1993). The species migrat- 
ing slower than ppetF in lanes a and b are differentially  glycosy- 
lated  forms  of  protease-protected  translocated  pc~F (1GpaF, 
2GpaF, 3GpaF) that are degraded upon addition  of detergent as 
in lanes  c. The presence of gtycosylated  paF indicates  that the 
competition for carbohydrate by the glyco-acceptor peptide was 
incomplete in this experiment. Note the stability of glycosylated 
and unglycosylated  pro-alpha factor (paF) in the 40- and 90-min 
samples. 
potF (Fig. 2). The presence of NYT peptide incompletely 
inhibited glycosylation in these experiments, and multiple 
forms of glycosylated pre-sequence cleaved pro-a factor 
species with one, two, or three attached core carbohydrate 
chains were present (Fig. 2, lpaF, 2paF, and 3paF). Signif- 
icantly, these core-glycosylated forms of pro-alpha factor 
were  stable during  the  chase with  cytosol. Furthermore, 
the  stability of glycosylated pro-alpha factor in  the  pro- 
tease treated samples (Fig. 2, lane b) showed that the addi- 
tion  of  cytosol  did  not  permeabilize  the  microsomes. 
ERAD  was  absent  when  BSA  instead  of  cytosol  was 
added  to  the  chase  reaction  (data  not  shown).  We  con- 
cluded from these results that cytosolic factor(s) were nec- 
essary and sufficient to reconstitute ERAD. 
To eliminate the possibility that addition of cytosol stim- 
ulated glycosylation of paF, thus reducing the pool of pelF 
in the microsomes, a second approach was used to gener- 
ate  unglycosylated  perF.  A  mutant  prepro-alpha  factor 
gene  was transcribed  and  translated  in  a  yeast lysate to 
produce  radiolabeled  prepro-alpha  factor  with  all  three 
glycosylation sites removed (AGppetF, see Materials  and 
Methods). To show that AGppetF was translocation-com- 
petent, we incubated yeast microsomes with the  radiola- 
beled precursor in the presence and absence of ATE The 
formation of protease protected unglycosylated paF was 
dependent  on  hydrolyzable  ATP  and  yeast  microsomes 
(Fig. 3). Furthermore, while the signal sequence of AGp- 
pctF was cleaved to yield paF, this product was not glyco- 
sylated.  These  results  demonstrated  that  AGppetF,  like 
wild-type ppaF, was translocation competent and could be 
used as a substrate in our in vitro ERAD assay. 
To test whether petF generated from AGppe~F was de- 
graded in  the  presence of cytosol, radiolabeled  ~GppoLF 
was translocated  into  yeast microsomes and  cytosol was 
added or omitted from the microsomes during the chase 
incubations.  In these  experiments,  potF was degraded  in 
the incubation reaction that contained cytosol but was sta- 
ble in the absence of cytosol (Fig. 4 a), confirming the cy- 
tosol-dependent nature of in vitro ERAD. 
Figure 2.  Unglycosylated  pro-alpha factor but not glycosylated 
pro-alpha factor is degraded by the addition  of cytosol. Translo- 
cation reactions  containing  wild-type yeast microsomes,  radiola- 
beled ppctF, and 0.02 txM NYT peptide were followed by 0-, 45-, 
and 90-min chase incubations  in the presence of NYT peptide 
and with or without  cytosol  (5 mg cytosolic protein/ml of reac- 
tion).  Samples  were  processed  as  described  in  Materials  and 
Methods.  Lane a, untreated samples; lane b, trypsin-treated sam- 
pies; lane c, samples treated with trypsin and Triton X-100. Note 
the disappearance of pctF in the 45- and 90-min incubation  sam- 
ples that contain  cytosol (+ cytosol) and the presence of paF in 
the 45 and 90 min samples without cytosol (- cytosol). Also, note 
that the glycosylated forms of pro-alpha factor are stable regard- 
less of the presence or absence of cytosol,  demonstrating sub- 
strate selectivity. 
McCracken and Brodsky  In Vitro  ERAD  293 Figure 3.  ATP and microsome-dependent translocation  of AGp- 
pe~F. Reactions containing the 35S-methionine  labeled species of 
ppctF lacking glycosylation acceptor sites (AGppaF)  were assem- 
bled in the presence or absence of wild-type microsomes and an 
ATP-regenerating system. After a 50-min incubation  at 20°C, the 
reactions  were distributed  to determine:  (a) total material, (b) 
protease  protected  material,  and  (c)  species  remaining  after 
treatment with protease in the presence of Triton-X 100. Reac- 
tions were processed and visualized as described in Materials  and 
Methods. 
Rapid Degradation of Unglycosylated Pro-Alpha 
Factor in the Cell-free System 
To determine the rate of degradation of paF in this sys- 
tem, the amounts of pctF remaining over the duration  of 
the chase incubation were quantified, averaged, and plots 
Figure  4.  Cytosol-dependent degradation  of  pro-alpha  factor 
produced by the  translocation and processing of AGppctF.  (a) 
Translocation reactions containing wild-type yeast microsomes 
and radiolabeled hGppetF were followed by 0-, 5-, 10-, 20-, and 
40-min chase incubations of washed microsomes resuspended in 
buffer or buffer containing cytosot  (+ cytosol).  All lanes repre- 
sent total TCA precipitated material from complete reactions 
(i.e., as in Fig. 3, lane 1). Note the disappearance of petF in the 
samples that contain cytosol and the stable presence of pctF in the 
samples without cytosol  supplement (-  cytosol).  (b)  Relative 
amounts of potF were  determined by volume analyses of the 
phosphorimages using the BioRad Phosphor Analyses program. 
Results from five experiments were averaged and presented with 
standard error bars. 
displaying the rate of decay were generated (Fig. 4 b). Re- 
suits from experiments using both approaches to generate 
petF indicated  that in vitro degradation  of paF was very 
rapid. By fitting these data to an exponential curve, a half 
life of 13  rain  was calculated  for ptxF.  This degradation 
rate is similar to that of pctF in vivo, as examined by Kur- 
jan and colleagues (Caplan et al., 1991).  Based on the de- 
cay curve and secretion data presented by these investiga- 
tors, we calculated the in vivo degradation half-life of paF 
to be ~15 min. 
Characterization of Factors Required for ERAD 
Because ERAD might require the activity of calcium-acti- 
vated proteases and  since the normally elevated concen- 
trations of lumenal calcium might have been lost upon mi- 
crosome formation, we examined whether calcium could 
replace the cytosol-dependence of ERAD in vitro. In ad- 
dition, the  ability of DTT to support cytosol-free ERAD 
in microsomes was examined because it was previously ob- 
served that DTT enhanced  the rate of ERAD in perme- 
abilized cells (Stafford and Bonifacino, 1991). Thus, exper- 
iments were  performed in  which  1.8  mM  Ca  2+,  0.5  mM 
DTT, and/or cytosol were added to the chase incubation 
samples. Neither Ca  2+ nor DTT alone were able to replace 
the  cytosol  dependence  of ERAD,  and  the  addition  of 
DTT or Ca  2+ did not have an enhancing effect on the cyto- 
sol dependent degradation of paF (data not shown). How- 
ever, it is noteworthy that our cytosol preparations were 
performed  in  the  presence  of  DTT  (see  Materials  and 
Methods). 
To determine if a  protein factor of the cytosol was re- 
quired for ERAD,  three experiments were performed in 
which heat-inactivated or trypsin-treated cytosol was used 
to analyze ERAD  (see Materials  and  Methods).  Results 
from these experiments showed that 94 _  6% of the ptxF 
remained  after a  20-min chase when supplemented  with 
heat inactivated cytosol, 66 -  9% of pctF remained after a 
20-min incubation with trypsin treated cytosol, while 20 _+ 
6%  of pelF  was  recovered  when  untreated  cytosol  was 
used. The fact that residual ERAD occurred with trypsin- 
treated cytosol might indicate  that the  required  cytosolic 
component(s) is partially protease-resistant. We concluded 
from these results that at least one protein component in 
the cytosol was required for ERAD in vitro. 
We  also  evaluated  in  vitro ERAD  in  the  presence  of 
ATP~S,  a  nonhydrolyzable analogue  of ATP.  Studies  in 
permeabilized cells have produced  conflicting  results re- 
garding  the  role  of ATP  in  this  process  (Leonard  and 
Chen, 1988; Megis and Simoni, 1992; Stafford and Bonifa- 
cino, 1992). We found that the addition of 1 mM ATP~,S to 
the chase incubations efficiently inhibited the degradation 
of pc~F; 91  --- 3%  of p~F remained in ATP'vS treated mi- 
crosomes after a 20-min chase compared to 20  __+  6%  re- 
maining when an ATP regeneration mix was added to the 
chase incubation (also see Fig. 7). These results suggested 
a requirement for ATP hydrolysis, a property not tested in 
the permeabilized cell system. 
Unglycosylated Pro-Alpha Factor Is Extruded 
from Microsomes 
Neither the responsible protease(s) nor the precise intra- 
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the possibility that  pelF was  exported to  the  cytosol for 
proteoloysis, we included a  centrifugation step  after the 
chase  reaction  to  separate  microsomes from cytosol. A 
small amount of petF was observed in the supernatant af- 
ter a 25-min chase in the absence of cytosol or in the pres- 
ence of heat inactivated cytosol and ATP (Fig. 5 and Table 
I). However, the percent of pelF in the cytosol fraction in- 
creased approximately threefold when the chase incubation 
reaction  included  cytosol  and  ATP.  Glycosylated  pro- 
alpha factor, generated using wild-type ppaF in the trans- 
location reaction, was not observed in the supernatant frac- 
tion in the presence or absence of cytosol (Fig. 5). 
Because our ERAD  chase conditions may support ve- 
sicular budding from the ER (Wuestehube and Schekman, 
1992), pctF could be exported by vesicular transport. To 
test  this  possibility  we  analyzed  ERAD  in  microsomes 
prepared from a  budding-defective secl2 strain  (C.  Bar- 
lowe, personal communication). In a 30-min ERAD assay, 
30 _+ 8% of pctF remained in microsomes prepared from 
an isogenic wild-type strain and 42 +__ 8% of paF was evi- 
dent in the sec12 microsomes. These results indicated that 
ERAD  occurs independent  of vesicle budding.  Further- 
more,  microsomes  from  both  strains  exhibited  cytosol/ 
ATP-enhanced release of pelF into the supernatant during 
the chase period (Table I). We also observed that the paF 
in the supernatant was trypsin sensitive (Fig. 5), indicating 
further that the substrate was not sequestered in transport 
vesicles. Together, these  results  suggest  that  ER-associ- 
ated degradation of pc~F occurs in the cytoplasm. 
Figure 5.  Unglycosylated pro-alpha factor is extruded from yeast 
microsomes. Either wild-type prepro-alpha factor (ppaF) or pre- 
pro-alpha  factor  lacking its  core  glycosylation consensus sites 
(AGppaF) was translocated into yeast microsomes and the mem- 
branes were isolated as described (Materials and Methods). After 
a 25-min chase reaction either containing or lacking cytosol and 
an ATP regeneration system, mierosomes were again harvested 
and the  pellets (P)  and supernatants (S)  were  analyzed as de- 
scribed (Materials and Methods). For the protease-treated reac- 
tions, the final pellet was first resuspended in buffer and the re- 
sulting pellet solution and supernatant were treated with 0.2 mg/ 
ml trypsin for 30 rain on ice. In this experiment, only 13% of the 
pctF was found in the supernatant in the absence of cytosol/ATP, 
while 36% of the paF was present in the supernatant in the pres- 
ence of cytosol/ATP. Triply glycosylated paF (3GppaF) was ab- 
sent from supernatant fractions even upon over-exposure of the 
gel (data not shown). As displayed in this figure, the migrations 
of AGppc~F and wild-type ppoLF differ slightly in 18% polyacryl- 
amide/4M urea gels. The appearance of pptaF in the supernatant 
fraction  in this  experiment represents  adhering untranslocated 
precursor and was not reproducibly observed. 
Calnexin Plays a Role in ERAD 
We next sought to discover that microsomal factors might 
be required for ERAD in our assay. A likely class of pro- 
teins is  the molecular chaperones, since they have been 
implicated in maturation and quality control of proteins in 
the ER (reviewed in  Gething and  Sambrook,  1992)  and 
are known to mediate selective targeting of protein sub- 
strates for degradation in both mitochondria and E.  coli 
(Gottesman and Maurizi, 1992; Craig et al., 1993; Sherman 
and Goldberg, 1993; Kandror et al., 1994; Wagner et al., 
1994).  To test the possibility that ER-localized molecular 
chaperones may be required for ERAD, we studied three 
mutant yeast strains (Aeugl, Ascjl, and Acnel), each with a 
gene disruption of an ER molecular chaperone. 
The EUG1 gene in yeast encodes a soluble ER resident 
protein with some sequence identity to protein disulfide 
isomerase  (PDI).  In  S.  cerevisiae, both  PDI  and  Euglp 
have  been  shown  to  be  functionally  related  and  are 
thought to interact with nascent proteins in the yeast ER 
(Tachibana and Stevens, 1992).  Scjlp, a yeast homologue 
of the E. coli DnaJ chaperone, resides in the ER and might 
modulate the activity of BiP, the ER luminal Hsp70 homo- 
logue (Blumberg and Silver, 1991; Schlenstedt et al., 1995). 
We  discovered  that  translocation  of  AGppe~F  into  mi- 
crosomes  prepared  from wild-type  and  null  strains  was 
equally efficient, and that there was no difference in the 
rate or extent of degradation of paF (Fig. 6). These results 
indicated that neither Euglp nor Scjlp was required for 
ERAD. 
We next examined ERAD in microsomes from a mutant 
strain with a disruption of the yeast calnexin gene, CNE1 
(Parlati et al.,  1995).  Calnexin plays a quality control role 
in the ER, assisting during initial folding of nascent pro- 
teins and retaining transport-incompetent misfolded pro- 
teins and incompletely assembled protein complexes in the 
ER (reviewed in Bergeron et al., 1994). Although calnexin 
has  not previously been shown to participate in ERAD, 
this  chaperone is  suitably positioned to target abnormal 
proteins for degradation. We discovered that degradation 
of paF in Ache1 microsomes was slower and less complete 
than in wild-type CNE1 microsomes (Fig. 7). These results 
indicated a role for calnexin in ERAD. 
Discussion 
We have developed a cell-flee assay to study ERAD using 
components from the yeast S. cerevisiae, and have demon- 
strated that a protein factor(s) of the cytosol and ATP hy- 
drolysis are essential for ERAD. The ability of cytosol to 
activate a process that occurs within the lumen of the ER 
is  not without precedent. For example, a  peptide trans- 
porter in the yeast microsomal membrane is activated by 
the  addition of exogenous cytosol (R6misch  and  Schek- 
man,  1992).  However, in  permeabilized  cell  assays  that 
measured ERAD, neither exogenous cytosol nor ATP was 
required for the degradation of Tac-TCRet chimera (Stafford 
and Bonifacino, 1991), asialoglycoprotein receptor (Wik- 
strom and Lodish, 1992), nor HMG CoA reductase (Megis 
and Simoni, 1992), although, an ATP-dependent degrada- 
tion  of HMG  CoA  reductase  in  permeabilized cells  has 
been reported (Leonard and Chen, 1987). The finding that 
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Chase Conditions* 
Buffer *  CytosoVATP  Buffer/ATP  HI cytosoVATP 
Membranes  P  S  P  S  P  S  P  S 
RSY607wt  88±0  12-+0  63 ±5  37_+5  81  ±6  19+-6  90±4  10-4 
SEC12wt  89±3  11 ±3  66-+2  34±2  ND  ND 
secl2  87 ±  6  13 ±  6  74 ±  3  26 +_ 3  ND  ND 
* Chase conditions included: buffer, buffer 88 without ATP regeneration system; cytosol/ATP, 5 mg/ml cytosol in buffer 88 plus ATP regeneration system; buffer/ATP, buffer 88 
plus ATP regeneration system; HI cytosol/ATP, heat-inactivated cytosol plus ATP regeneration system. 
*Values are expressed as mean percent --. SD of total paF present in the pellet (P) and supernatant (S) after a 25-min chase incubation, for at least two independent experiments 
(each performed in duplicate). Microsomes were prepared from the indicated strains, assayed for in vitro ERAD, and micro-centrifuged (12,000 rpm) at 4°C for 2 rain after the 
chase incubation to separate the microsomes from the cytosol. Supernatant and pellet samples were each TCA precipitated, resolved by SDS-PAGE, and quantified as described in 
Materials and Methods. 
ERAD occurs in permeabilized cells in the absence of ex- 
ogenous ATP and cytosol should not be interpreted as ev- 
idence that  ERAD  does not require  these  components, 
since residual  ATP and cytosolic factors may remain  in 
permeabilized  cells  but  become  lost  during  microsome 
preparation. A  more accurate assessment of the potential 
role of ATP and cytosolic factors in the degradative pro- 
cess itself may be possible in a cell-free system. The devel- 
opment of this in vitro assay thus provides a method for 
the molecular dissection of the ERAD process. 
How  might  cytosolic  factors  function  in  ERAD?  It 
could be argued that the cytosol preparation contains pro- 
teases that selectively degrade ptxF but not glycosylated 
pro-alpha  factor.  This  hypothesis  requires  that  the  mi- 
crosomes become permeable to proteases during the chase 
incubation, or that translocated, protease-protected paF is 
selectively pumped out of the microsomes for degradation 
in the cytosol. To minimize vacuolar protease contamina- 
tion, cytosol was prepared from a strain containing muta- 
tions in three vacuolar protease genes (see Materials and 
Methods).  To  directly  address  the  possibility  that  mi- 
crosomes are permeable to proteases, we measured the in- 
tegrity  of  the  microsomal  membrane  by  determining 
whether paF or glycosylated pro-alpha factor became ac- 
cessible to exogenously added trypsin. As shown in Fig. 1 
(lane b), these products are not degraded by trypsin even 
after the  90-min  chase  period.  In  addition,  microsomes 
supplemented with cytosol are not permeable to proteases 
as  demonstrated  by the  stability of glycosylated petF in 
trypsin treated samples (Fig. 2, lane b). 
The second possibility, that  petF is  released from mi- 
crosomes for degradation in the cytosol, is supported by 
our results that show petF is exported to the cytosol via a 
selective transport process that is activated by conditions 
that support ERAD and glycopeptide export from the ER, 
i.e., cytosol and ATP (see Table I and Fig. 5; R6misch and 
Schekman,  1992).  Furthermore,  we  have  evidence  that 
mutations in genes encoding a chymotrypsin-like subunit 
of  the  yeast  proteasome  complex  (Heinemeyer  et  al., 
1991) inhibit degradation of ERAD substrates in vivo and 
in vitro (Werner and McCracken, manuscript in prepara- 
tion). Together, these data implicate the cytosol as the site 
of degradation. 
Our results also demonstrate that yeast calnexin has a 
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Figure  6.  Decay  curve  of pro-alpha  factor  in  microsomes pre- 
pared from wild-type and mutant strains with disrupted SCJ1  or 
EUG1  genes.  Translocation  reactions  with  either  wild-type 
(SCJl-wt, EUGI-wt) or mutant microsomes containing gene dis- 
ruptions (zascjl,  Aeugl) were followed by chase incubations sup- 
plemented  with  cytosol.  Pro-alpha  factor  was  visualized  and 
quantified by phosphorimage analyses as described in Materials 
and Methods. Averaged data of three or more experiments are 
presented and the standard error ranged from +4 to +10%. 
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Figure  7.  Decay  curve  of pro-alpha  factor  in  microsomes pre- 
pared from wild-type and mutant strains with a  disrupted CNE1 
gene. An isogenic wild-type strain (CNEI-wt) and a mutant strain 
containing  a  disrupted  CNE1  gene  (Llcnel)  were  analyzed  for 
ERAD  as previously described in Materials and Methods. Cyto- 
sol was added to  all chase incubation samples containing either 
the ATP regeneration system or 1 mM ATP~S (CNE1 + ATPyS). 
Averaged data of three or more experiments is presented -+SE. 
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Thomas and colleagues previously demonstrated that cal- 
nexin acts as a constituent of the ER quality control appa- 
ratus in yeast (Parlati  et al.,  1995).  Perhaps  the calnexin 
mediated retention of misfolded substrates in the ER facil- 
itates their targeting for rapid degradation. This hypothe- 
sis is supported by the evidence that two mutant proteins 
known  to  be  degraded  by  ERAD  are  among  those  re- 
tained in the ER by interaction with calnexin: alpha-1 pro- 
tease  inhibitor  (McCracken  and  Kruse,  1993;  Le  et  al., 
1994) and AF508 CFTR (Pind et al., 1994). 
Much evidence indicates that molecular chaperones in- 
teract  with specific  partner proteins  that specialize  their 
functions  for  protein  trafficking,  protein  translocation, 
gene expression,  and proteolysis  (reviewed  in Rassow  et 
al., 1995). It is conceivable that such a partner may special- 
ize calnexin function for a role in ERAD, or that calnexin 
may act as a partner for another chaperone. An example 
of such coordinate interactions leading to degradation of 
misfolded proteins is seen in the mitochondria. The ATP- 
dependent proteolytic degradation of misfolded  proteins 
in the mitochondrial matrix by the PIM1 protease is medi- 
ated by the mitochondrial molecular chaperone mt-hsp70 
and one of its partner proteins, Mdjlp. In the absence of 
Mdjlp,  misfolded  proteins  either remain  associated  with 
mt-hsp70 or form  aggregates  that are  not substrates  for 
PIMlp  (Wagner  et  al.,  1994).  In  addition,  complexes  of 
calnexin  with misfolded  proteins  and BiP/Grp78,  an ER 
luminal  Hsp70  family  chaperone,  have  been  observed 
(Hammond  and  Helenius,  1994).  Perhaps  calnexin  and 
BiP cooperate to prevent the aggregation of aberrant pro- 
teins and mediate their degradation. The membrane loca- 
tion of calnexin could facilitate  targeting of the aberrant 
proteins to a transporter for release to the cytoplasm. 
It is important to note that calnexin has been shown to 
serve primarily as a lectin, binding specifically to glycosy- 
lated proteins (Ou et al., 1993; Hammond et al., 1994; He- 
bert et al., 1995). However, calnexin also binds to proteins 
that lack  N-linked glycans  (Rajagoplan et  al.,  1994; Kim 
and Arvan, 1995), and there is evidence that calnexin in- 
teracts with unfolded proteins by binding to polypeptides 
rather than glycan determinants (Zhang et al., 1995). Since 
no evidence is currently available in yeast to assess the na- 
ture of calnexin binding, the possibility exists that calnexin 
interacts  directly  with  unglycosylated  pe~F. Studies  to 
probe the interaction of calnexin with petF will be required 
to support this premise. 
In conclusion, we have reconstituted ER-associated pro- 
tein degradation in vitro, and have demonstrated that pro- 
tein  components  of  the  cytoplasm  are  required  for  this 
process.  This  cell-free  system  reveals  a  requirement  for 
ATP hydrolysis and a role for calnexin in ERAD, and im- 
plicates  the cytosol as the site  for proteolysis  of ERAD 
substrates. Further application of this in vitro system will 
allow the biochemical fractionation of cytosol to identify 
relevant  factors,  studies  with protease-specific  inhibitors 
and  proteosome  defective  mutants  to  define  the  pro- 
teolytic  activity,  experiments  to probe  the interaction of 
calnexin and BiP with ERAD substrates, and the testing of 
ERAD-deficient  mutants  to  characterize  their  defects. 
The  research  challenge  is  to  identify  additional  compo- 
nents of ERAD,  to understand how this process  works, 
and particularly how it is controlled. We expect that an- 
swers to these questions will provide information of broad 
applicability, which will illuminate other areas of cellular 
control and intracellular trafficking of biomedically impor- 
tant proteins. 
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